PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C

Schering is now introducing PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C.

PEG-Intron is the first "pegylated" interferon.

It's made by linking polyethylene glycol (PEG) to Intron-A (interferon alfa-2b). PEG slows the metabolism of the interferon and makes it longer-acting.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote